Adrenal suppression and growth retardation from ocular corticosteroids

Journal of Pediatric Ophthalmology and Strabismus

Volumn 38, Issue 3, 2001, Pages 177-178

  Steelman, Joel ^a   Kappy, Michael ^a  

^a CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISOLONE;

ADRENAL DISEASE; ADRENAL SUPPRESSION; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; FEMALE; GROWTH RATE; GROWTH RETARDATION; HUMAN; PROVOCATION TEST; TREATMENT OUTCOME; TREATMENT PLANNING;

ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; CHILD; CUSHING SYNDROME; FEMALE; GLUCOCORTICOIDS; GROWTH DISORDERS; HUMANS; OPHTHALMIC SOLUTIONS; PREDNISOLONE;

EID: 0035031813     PISSN: 01913913     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Vanderschueren-Lodeweyckx M, Wolter R, Malvaux P, Eggermont E, Eeckels R. The glucagon stimulation test: effect on plasma growth hormone and on immunoreactive insulin, cortisol, and glucose in children. J Pediatr. 1974;85:182-187.
2. Thaler LM, Blevins LS Jr. The low dose (1-μg) adrenocorticotropin stimularion test in the evaluation of patients with suspected central adrenal insufficiency. J Clin Endocrinol Metabol. 1998;83:2726-2729.
3. Frauman AG. An overview of the adverse reactions to adrenal corticosteroids. Adverse Drug React Toxicol Rev. 1996;15:203-206.
4. Burch PG, Migeon CJ. Systemic absorption of topical steroids. Arch Ophthalmol. 1968;79:174-176.
5. Doull IJM, Freezer HN, Holgate ST. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone diproprionate. Am J Respir Crit Care Med. 1995;151:1715-1719.
6. Boot AM, De Jongste JC, Verberne A, Opols H, De Muinck S. Bone mineral density and bone metabolism of prepubertal children with asthma after long-term treatment with inhaled corticosteroids. Pediatr Pulmonol. 1997;24:379-384.
7. Gilbertson EO, Spellman MC, Piacquadio DJ, Mulford MI. Super potent topical corticosteroid use associated with adrenal suppression: clinical considerations. J Am Acad Dermatol. 1998;38:318-321.
8. Grahnen A, Eckernas SA, Brundin RM, Ling-Anderson A. An assessment of the systemic activity of single doses of inhaled fluticasone proprionate in healthy volunteers. Br J Clin Pharmacol. 1994;38:521-525.